摘要
目的 研究微生态制剂丽珠肠乐治疗肝硬化腹泻的疗效。方法 采用前瞻性研究方法 ,将 1998年 4月至 2 0 0 1年 7月 6 3例肝硬化腹泻患者随机分为治疗组及对照组两组 ,治疗组 (n =32 )服用丽珠肠乐治疗 ,对照组(n =31)服用氧氟沙星治疗 ,分别观察其腹泻好转情况。结果 治疗组总有效率是 93 72 % ,而对照组总有效率是5 4 85 % ,两组间有显著性差异 (P <0 .0 5 )。
Objective To study the effect of P.O.Bifidobiogen treating diahrrhea caused by hepatocirrhosis.Method With a prospective research approach, 63 people who suffered from hepatocirrhosis diahrrhea were randomly divided into two groups: the treated group (n=32) taking P.O.Bifidobiogen and the contrast group (n=31) taking Ofloxacin, so that the effect of the two drugs on treating the diahrrhea of the two groups of subjects were respectively observed.Result A total curative effect of 93.72% was experienced by the treated group, and 54.85% by the contrast group, which indicates a remarkable difference (P<0.05) between the two groups.Conclusion P.O.Bifidobiogen bears a notable curative effect in treating hepatocirrhosis diahrrhea.
出处
《热带医学杂志》
CAS
2002年第1期52-53,共2页
Journal of Tropical Medicine
关键词
微生态制剂
丽珠肠乐
肝硬化
腹泻
治疗
micro-ecological production
P.O.Bifidobiogen
hepatocirrhosis
diahrrhea
